SouthState’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.4K Buy
64
+25
+64% +$2.69K ﹤0.01% 686
2026
Q2
$2.75K Hold
39
– – ﹤0.01% 891
2026
Q1
$1.99K Buy
39
+15
+63% +$700 ﹤0.01% 902
2025
Q4
$714 Sell
24
-59
-71% -$1.6K ﹤0.01% 1173
2025
Q3
$2.15K Sell
83
-244
-75% -$6.81K ﹤0.01% 922
2025
Q2
$9.03K Buy
327
+143
+78% +$3.77K ﹤0.01% 804
2025
Q1
$5.22K Buy
+184
New +$6.53K ﹤0.01% 977
2024
Q4
– Hold
0
– – – 672
2024
Q3
– Sell
-22
Closed -$2.02K – 607
2024
Q2
$2.64K Buy
+22
New +$2.78K ﹤0.01% 581
2023
Q4
– Sell
-220
Closed -$22.7K – 653
2023
Q3
$22.7K Buy
220
+70
+47% +$7.81K ﹤0.01% 396
2023
Q2
$18.2K Hold
150
– – ﹤0.01% 425
2023
Q1
$23K Hold
150
– – ﹤0.01% 430
2022
Q4
$26.9K Hold
150
– – ﹤0.01% 435
2022
Q3
$18K Hold
150
– – ﹤0.01% 473
2022
Q2
$21K Hold
150
– – ﹤0.01% 489
2022
Q1
$26K Hold
150
– – ﹤0.01% 508
2021
Q4
$38K Hold
150
– – ﹤0.01% 430
2021
Q3
$58K Buy
+150
New +$55.3K ﹤0.01% 340

Other funds holding MRNA

SouthState's MRNA Position: Q3 2026 in Review

SouthState increased its Moderna (MRNA) stake by 64% in Q3 2026, buying an estimated $2.69K and bringing the position to 64 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #686.

SouthState first reported a position in MRNA in Q3 2021 and has held it in 17 quarters since. The position peaked at $58K in Q3 2021. 875 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • SouthState held 64 shares of Moderna worth $12.4K as of Q3 2026.
  • SouthState bought 25 Moderna shares in Q3 2026, an estimated $2.69K.
  • Moderna made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #686 holding.
  • SouthState first reported a position in Moderna in Q3 2021 and has held it in 17 quarters since.
  • SouthState's Moderna position peaked at $58K in Q3 2021.
  • 875 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.